ES2075161T3 - Agente de prevencion y terapeutico para la hepatitis. - Google Patents

Agente de prevencion y terapeutico para la hepatitis.

Info

Publication number
ES2075161T3
ES2075161T3 ES90309859T ES90309859T ES2075161T3 ES 2075161 T3 ES2075161 T3 ES 2075161T3 ES 90309859 T ES90309859 T ES 90309859T ES 90309859 T ES90309859 T ES 90309859T ES 2075161 T3 ES2075161 T3 ES 2075161T3
Authority
ES
Spain
Prior art keywords
hepatitis
therapeutic agent
prevention
prostaglandina
preventive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90309859T
Other languages
English (en)
Inventor
Masahiro Watanabe
Kazumasa Yokoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Taisho Pharmaceutical Co Ltd
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16985315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2075161(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Green Cross Corp Japan, Taisho Pharmaceutical Co Ltd, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Application granted granted Critical
Publication of ES2075161T3 publication Critical patent/ES2075161T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

AGENTE PREVENTIVO Y TERAPEUTICO DE LA HEPATITIS QUE CONSTA DE UNA EMULSION GRASA QUE CONTIENE UN COMPUESTO CON ACTIVIDADES DE PROSTAGLANDINA E1.
ES90309859T 1989-09-11 1990-09-10 Agente de prevencion y terapeutico para la hepatitis. Expired - Lifetime ES2075161T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1235386A JPH03101622A (ja) 1989-09-11 1989-09-11 肝炎予防治療剤

Publications (1)

Publication Number Publication Date
ES2075161T3 true ES2075161T3 (es) 1995-10-01

Family

ID=16985315

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90309859T Expired - Lifetime ES2075161T3 (es) 1989-09-11 1990-09-10 Agente de prevencion y terapeutico para la hepatitis.

Country Status (8)

Country Link
US (1) US5091417A (es)
EP (1) EP0418004B1 (es)
JP (1) JPH03101622A (es)
KR (1) KR910005872A (es)
CA (1) CA2024965A1 (es)
DE (1) DE69021304T2 (es)
DK (1) DK0418004T3 (es)
ES (1) ES2075161T3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
ATE174221T1 (de) * 1990-05-01 1998-12-15 R Tech Ueno Ltd Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
US5348764A (en) * 1992-10-06 1994-09-20 Yasuhiro Yokoshima Method for impregnating a lining material with a hardenable resin
SE9302295D0 (sv) * 1993-07-02 1993-07-02 Kabi Pharmacia Ab New pharmaceutical composition
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
EP0857484A4 (en) * 1995-09-13 2000-12-06 Nippon Shinyaku Co Ltd PGE1- FREEZING DRIED PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
KR20000070903A (ko) * 1997-02-10 2000-11-25 오노 야꾸힝 고교 가부시키가이샤 11,15-ｏ-디알킬프로스타글란딘 ｅ 유도체, 이것의 제조 방법 및 이것을 유효 성분으로 함유하는 약제
US6553644B2 (en) 2001-02-09 2003-04-29 International Business Machines Corporation Fixture, carrier ring, and method for processing delicate workpieces
EP1981524A2 (en) * 2006-02-09 2008-10-22 Schering Corporation Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤
JPS59216820A (ja) * 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd プロスタグランジン脂肪乳剤
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
JPS60181068A (ja) * 1984-02-29 1985-09-14 Teijin Ltd ６−置換プロスタグランジンｅ↓１類およびその製造法

Also Published As

Publication number Publication date
DK0418004T3 (da) 1995-09-18
DE69021304T2 (de) 1996-01-18
KR910005872A (ko) 1991-04-27
DE69021304D1 (de) 1995-09-07
EP0418004A3 (en) 1991-12-27
US5091417A (en) 1992-02-25
CA2024965A1 (en) 1991-03-12
EP0418004A2 (en) 1991-03-20
EP0418004B1 (en) 1995-08-02
JPH03101622A (ja) 1991-04-26

Similar Documents

Publication Publication Date Title
ES2156839T1 (es) Medicamento que contiene alginato e implante para tratar la fibrosis.
MX9306499A (es) Composiciones farmaceuticas que contienen una anfetamina.
MX9203226A (es) Derivados de fenetanolamina y composicion farmaceutica que los contiene.
MX9203027A (es) Derivados heterociclicos de acilaminotiazoles y composicines farmaceuticas que los contienen.
MX9202934A (es) Derivados de carbostirilo y composicion farmaceutica que los contiene.
ES8705762A1 (es) Procedimiento para preparar un agente analgesicamente activo a base de 2-amino-3-carboetoxiamino-6-(4-fluorobencilamino)-piridina y por lo menos un agente antiflogistico no esteroidal
MY119711A (en) Method of inhibiting photoaging of skin
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
GT199800126A (es) Terapia de combinacion.
ES2137372T3 (es) Solucion antifungica para las uñas.
ES2075161T3 (es) Agente de prevencion y terapeutico para la hepatitis.
MX9207383A (es) Derivados de 2-imidazolin-5-onas y 2-imidazolin-5-tionas, procedimiento para su preparacion y composiciones fungicidas que los contienen.
MX9204563A (es) Nuevos derivados de la (2-alquil-3-piridil)-metilpiperazina y composicion farmaceutica que los comprende.
ES2063060T3 (es) Benzamida contra enfermedades cognoscitivas.
MX9201058A (es) Derivados ciclicos de cetal, procedimiento para supreparacion y composicion farmaceutica que los contiene.
CO4600725A1 (es) Composiciones insecticidas sinergisticas
MX9202763A (es) Nuevos derivados de 2-(1-piperazinil)-4-fenil-cicloalcanopiridina y composicion farmaceutica que los contiene.
ES2058451T3 (es) Un metodo para la preparacion de una composicion farmaceutica.
DK0613368T3 (da) Hudregenererende kosmetisk sammensætning
MX9206516A (es) Parasiticidas de formazano, proceso para su preparacion y composicion parasiticida que los contiene.
AR228255A1 (es) Procedimiento para la produccion de una preparacion sinergistica que tiene una actividad analgesica y miotonolitica mejorada
MX9203383A (es) Nuevos derivados de piridobenzoindol y composiciones farmaceuticas que los contienen.
MX9203021A (es) Derivados de carbostirilo y composicion farmaceutica que los contiene.
DK102988D0 (da) Middel med antidepressiv virkning
MX9206135A (es) Metodos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 418004

Country of ref document: ES